Dr. Ravi Shankar Aysola, MD

Dr. Aysola practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Aysola's NPI, 1710008834, was assigned on April 3, 2007. Dr. Aysola graduated from UT Southwestern Medical Center in 2000. Dr. Aysola holds California license A102842.

Dr. Aysola's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Aysola's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Aysola is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Aysola to 1 more community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aysola practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Aysola's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Aysola is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Aysola's licenses on file in 3 states: California, Missouri and Texas.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, insomnia, intellectual and developmental disabilities, muscle disease and restless legs syndrome among the conditions Dr. Aysola treats.

CMS data shows 673 Medicare services from Dr. Aysola across 9 procedure codes in 2024, for 397 Medicare patients. Medicare paid $59,564 for them.

CMS counts 397 Medicare patients who saw Dr. Aysola in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aysola's median patient age at 55, with 42% women.

In 2024, Dr. Aysola wrote 633 Medicare Part D claims for 123 patients. 66% of them were for generic drugs. CMS names the drug for 479 of them, across 22 drugs with 11 or more claims each, at $286,678 in total drug cost. In 2023, CMS named 550 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Aysola for performance year 2024, reported as part of a group. Dr. Aysola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aysola as offering telehealth.

Dmand AI links 25 papers to Dr. Aysola, published from 2008 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Sleep Apnea, Obstructive, Magnetic Resonance Imaging and Brain. Dr. Aysola has published most often in J Clin Sleep Med. Dr. Aysola's most frequent co-authors are Daniel Won Kang, MD, MPH, Daniel Kang, MD and Rajesh Kumar, MD.

CMS Open Payments shows 15 general payments to Dr. Aysola from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Inspire Medical Systems, Inc. paid the most, $5,379.

Dr. Aysola graduated from UT Southwestern Medical Center in 2000.

Dr. Aysola is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.